QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
OTCMKTS:PHGUF

Pharming Group - PHGUF Stock Forecast, Price & News

$1.03
0.00 (0.00%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.03
$1.03
50-Day Range
$0.97
$1.45
52-Week Range
$0.74
$1.45
Volume
N/A
Average Volume
337 shs
Market Capitalization
$671.98 million
P/E Ratio
25.76
Dividend Yield
N/A
Price Target
N/A

PHGUF stock logo

About Pharming Group (OTCMKTS:PHGUF) Stock

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.

Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHGUF Stock News Headlines

Stock Market Update
This stock is taking America by storm. Find out why it's trending right now.
Pharming Group N.V.: Notice of Full Year 2022 financial results
Notice of Full Year 2022 financial results
Stock Market Update
This stock is taking America by storm. Find out why it's trending right now.
Pharming Group Notice of Q3 Results
Pharming Group NV
Pharming Group - Stock Quote PHGUF
See More Headlines
Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHGUF Company Calendar

Last Earnings
3/05/2015
Today
3/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PHGUF
CIK
N/A
Employees
277
Year Founded
N/A

Profitability

Net Income
$16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$198.87 million
Cash Flow
$0.06 per share
Book Value
$0.31 per share

Miscellaneous

Free Float
N/A
Market Cap
$671.98 million
Optionable
Not Optionable
Beta
1.10

Key Executives

  • Sijmen de Vries
    Chief Executive Officer & Executive Director
  • Mireille Sanders
    Chief Operations Officer
  • Jeroen Henk Wakkerman
    Chief Financial Officer
  • Robert Friesen
    Chief Scientific Officer
  • Anurag Relan
    Chief Medical Officer













PHGUF Stock - Frequently Asked Questions

How have PHGUF shares performed in 2023?

Pharming Group's stock was trading at $1.1499 at the start of the year. Since then, PHGUF shares have decreased by 10.4% and is now trading at $1.03.
View the best growth stocks for 2023 here
.

Are investors shorting Pharming Group?

Pharming Group saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 2,709,800 shares, a decline of 16.4% from the February 13th total of 3,240,100 shares. Based on an average trading volume of 400 shares, the short-interest ratio is currently 6,774.5 days.
View Pharming Group's Short Interest
.

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) released its quarterly earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.01. Pharming Group had a trailing twelve-month return on equity of 15.52% and a net margin of 14.90%.

What is Pharming Group's stock symbol?

Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."

How do I buy shares of Pharming Group?

Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharming Group's stock price today?

One share of PHGUF stock can currently be purchased for approximately $1.03.

How much money does Pharming Group make?

Pharming Group (OTCMKTS:PHGUF) has a market capitalization of $671.98 million and generates $198.87 million in revenue each year. The biotechnology company earns $16 million in net income (profit) each year or $0.04 on an earnings per share basis.

How many employees does Pharming Group have?

The company employs 277 workers across the globe.

How can I contact Pharming Group?

Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The official website for the company is www.pharming.com. The biotechnology company can be reached via phone at (171) 524-7400, via email at investor@pharming.com, or via fax at 31-0-71-524-7445.

This page (OTCMKTS:PHGUF) was last updated on 3/21/2023 by MarketBeat.com Staff